Dalpiciclib 100mg Clinical Trials
3 recruitingDrug
Phase 12Phase 21
Showing 1–3 of 3 trials
Recruiting
Phase 2
Efficacy and Safety of Dalpiciclib Combined With Endocrine Adjuvant Therapy for Early HR +/HER2- Breast Cancer: a Multicenter, Prospective Clinical Study
Breast NeoplasmsBreast DiseasesCDK4/6 Inhibitor+3 more
Fujian Cancer Hospital2,000 enrolled2 locationsNCT07581834
Recruiting
Phase 1
Neoadjuvant Camrelizumab With Dalpiciclib for Resectable Head and Neck Squamous Cell Carcinomas
Head and Neck Squamous Cell Carcinoma
West China Hospital6 enrolled1 locationNCT06109207
Recruiting
Phase 1
Neoadjuvant Adebrelimab With Dalpiciclib for Resectable Esophageal Squamous Cell Carcinomas
Esophageal Squamous Cell Carcinoma
West China Hospital6 enrolled1 locationNCT06225921